Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Neoplasm”

1,853 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,853 results

Testing effectiveness (Phase 2)Looking for participantsNCT06173219
What this trial is testing

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Who this might be right for
Advanced Solid Tumor
China-Japan Friendship Hospital 38
Early research (Phase 1)Ended earlyNCT04186637
What this trial is testing

An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies

Who this might be right for
Advanced Solid TumorLymphoma
Alpine Immune Sciences, Inc. 62
Early research (Phase 1)Study completedNCT05396300
What this trial is testing

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophageal CancerStomach Cancer+3 more
Weijia Fang, MD 43
Early research (Phase 1)Study completedNCT03192345
What this trial is testing

A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumor
Sanofi 161
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Ended earlyNCT02192567
What this trial is testing

Open Label Study of DS-5573a

Who this might be right for
Advanced Solid Malignant Tumors
Daiichi Sankyo Co., Ltd. 19
Early research (Phase 1)Study completedNCT03521037
What this trial is testing

Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor

Who this might be right for
Neoplasms
pharmaand GmbH 16
Early research (Phase 1)UnknownNCT04122339
What this trial is testing

MAX-10181 Given Orally to Patients With Advanced Solid Tumor

Who this might be right for
Solid Tumor
Maxinovel Pty., Ltd. 30
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT04204434
What this trial is testing

Biomarkers For Immune Checkpoint Inhibitors

Who this might be right for
Advanced CancerNeoplasms
Rhode Island Hospital 119
Early research (Phase 1)Ended earlyNCT05144334
What this trial is testing

BTX-1188 in Subjects With Advanced Malignancies

Who this might be right for
Advanced Solid TumorNon Hodgkin LymphomaAcute Myeloid Leukemia
Biotheryx, Inc. 8
Early research (Phase 1)Study completedNCT01546428
What this trial is testing

A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Novartis Pharmaceuticals 44
Early research (Phase 1)Looking for participantsNCT06426680
What this trial is testing

The ILB-3101 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Innolake Biopharm 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Ended earlyNCT05631327
What this trial is testing

A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumor
Jazz Pharmaceuticals 12
Early research (Phase 1)Looking for participantsNCT06120283
What this trial is testing

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced Breast CancerMetastatic Breast Cancer+6 more
BeOne Medicines 399
Early research (Phase 1)Enrolling By InvitationNCT05423977
What this trial is testing

Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
Hangzhou Adcoris Biopharmacy Co., Ltd 36
Early research (Phase 1)Study completedNCT06048367
What this trial is testing

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor

Who this might be right for
Advanced Solid TumorLung CancerPancreas Cancer+6 more
Sichuan Enray Pharmaceutical Sciences Company 19
Testing effectiveness (Phase 2)Looking for participantsNCT05103345
What this trial is testing

Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Guangzhou Sinogen Pharmaceutical Co., Ltd 70
Early research (Phase 1)Study completedNCT02000934
What this trial is testing

TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies

Who this might be right for
Advanced Solid Tumor and Lymphoma Malignancies
Calithera Biosciences, Inc 143
Load More Results